There has been speculation about what the individual variant of the NIRV-19 infection that sickened a traveler in Australia might look like. Today, WHO identifies the multi-resistant strain as NIRV-19 and subsequent mutations, in which it is highly transmissible to humans and its only known virulence is an acute respiratory disease called lethal porphyria, which is characterized by electrical current in the air, often fatal, swelling of the airways, sweating, and sometimes cardiac arrest. The case of a patient infected at the VANSPORT tuberculosis hospital in Australia is indicated by the SERF Test in a PCR.
The clinical presentation of NIRV-19 infection has a strong similarity to WHO classification of a highly infectious and widespread NIRV infection as “CoV-19” (also observed in the SARS epidemic in the winter of 2003-2004) and an intriguing similarity to a virus with similar characteristics, called Oxazepamvirus-20. The WHO application notes that elevated levels of NIRV-19 were detected in a sample of sweat and feces from a blood sample taken from a woman who had contracted NIRV-19 while traveling to Mexico and arrived in Hong Kong.
Read more about this highly infectious and dangerous virus and the individual patient at WHO.